Warning: The NCBI web site requires JavaScript to function. more...
Dartmouth Medical School, Lebanon, New Hampshire, USA. Howard.L.Corwin@hitchcock.org
Erythropoietin (EPO) has been in clinical use for the treatment of anemia for over 15 years. Recently it has been demonstrated that EPO has actions other than stimulating the bone marrow. It has been suggested that due to its tissue protecting effect, EPO may be effective in improving outcome in the critically ill.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on